Loading Radix Peptides
Preparing this page…
Loading Radix Peptides
Preparing this page…

10mg Lyophilized Peptide
GHRH analog studied for visceral fat research.
Tesamorelin is a growth hormone releasing hormone (GHRH) analogue consisting of standard GHRH to which an additional trans-3-hexanoic acid group has been added. Tesamorelin became the newest peptide to be approved by the FDA for use in HIV-associated lipodystrophy in 2010. The peptide has also been investigated for its ability to improve peripheral nerve regeneration and as a potential intervention for mild cognitive impairment (MCI), the precursor to dementia.
Source: PubMed
Research use only. This product is intended strictly for laboratory research and is not for human or veterinary use, diagnosis, or treatment. Read the human-consumption FAQ.
Third-party analytical documentation for Tesamorelin.
Store lyophilized powder at -20°C, protected from light and moisture. After reconstitution, refrigerate at 2–8°C and use within 30 days. Avoid repeated freeze–thaw cycles.
Published third-party analytical documentation for this research compound.
Load the complete certificate when you are ready to view it. The PDF is not downloaded during the initial page load.
Load the complete certificate when you are ready to view it. The PDF is not downloaded during the initial page load.